Effect on perfusion chamber thrombus size in patients with atrial fibrillation during anticoagulant treatment with oral direct thrombin inhibitors, AZD0837 or ximelagatran, or with vitamin K antagonists
Authors : Wolzt M; Eriksson UG; Gouya G; Leuchten N; Kapiotis S; Elg M; Schützer KM; Zetterstrand S; Holmberg M;
Affiliations : Department of Clinical Pharmacology, Medical University of Vienna, Austria Corresponding author at: Universitätsklinik für Klinische Pharmakologie, Allgemeines Krankenhaus Wien, Währinger Gürtel 18–20, A-1090 Vienna, Austria. Tel.: +43 1 40400 2981; fax: +43 1 40400 2998
Journal : Thrombosis Research (2011)
Related Links: Pubmed | Publisher website
ISLAA 2022-Left Atrial Appendage
Dr. Dhanunjay Lakkireddy, MD, F.A.C.C, FHRS, The Kansas City Heart Rhythm Institute (KCHRI), KS, USA.
Display Ads on JAFIB to reach Users world wide...
Suggest an Event to get good mileage from Users World wide...